Companies

Zydus Cadila gets USFDA’s nod for Candesartan Cilexetil, HCl tablets

Mumbai, November 30, 2017:  Pharma Major, Zydus Cadila has received the final approval from the United States Food and Drug Administration (USFDA) to market Candesartan Cilexetil and Hydrochlorothiazide Tablets USP in the strengths of 16 mg/12.5 mg, 32 mg/12.5...

Dabur keen to extend baby-care portfolio with new offerings

Kolkata, May 12, 2015: Dabur India is looking to extend its presence in the baby care portfolio with new offerings in the coming days. So far, Dabur’s baby care portfolio includes massage oil Dabur Lal Tail and supplements such...

Torrent Pharma to acquire Zyg Pharma

New Delhi, May 12, 2015 Drug firm Torrent Pharmaceuticals has inked an agreement to fully acquire Zyg Pharma, part of Encore Group, for an undisclosed amount. “The company has signed a share purchase agreement to acquire 100 per cent...

100-year-old pharma company hooks on to Net

Chennai-based Dadha Pharma to launch online service The recent online retail wave has swept along not only new age entrepreneurs but also 100-year-old brick-and-mortar companies. Chennai-based Dadha Pharmaceuticals is one of them. The Dadha group will soon...

A three-day workshop i.e. 5th to 7th April 2015 entitled Quality Improvement Programme on...

Himachal Pradesh, April 20, 2015 - A three-day workshop i.e. 5th to 7th April 2015 entitled Quality Improvement Programme on Training Teachers for Tomorrow’s Need was organised by Association of Pharmaceutical Teachers of India-HP State Branch in association with...

GVK Bio aims to expand in biotech space with Aragen buy

Hyderabad, March 22,2014 - Clinical research and development firm GVK Bio is hoping to leverage its acquisition of US biologics services company Aragen Biosciences to gain a foothold in the growing biosimilars research market. The Indian drug discovery...

LANXESS brings a smile to the faces of the special children of Jidd school...

 Thane, October 26, 2013: LANXESS India Private Limited, the leading specialty chemicals company, is supporting yet another cause, as a part of its commitment towards education and welfare of the society. Continuing its social responsibility programme, the company has...

Rockland Hospital Launches its Cardiac Department

New Delhi, August 30, 2013: Mrs Preneet Kaur, Minister of State for External Affairs inaugurated the Cardiac Department today at the Rockland Hospital, Qutab institutional area, South Delhi. Led by Dr Harsh Wardhan, Chairman Cardiology, the Rockland Cardiac leadership...

BGS Global Hospitals Hosts First of its Kind Innovative Collaborative Workshop in the Country

Bangalore, July 17, 2013: iENT Conference and Live Surgical Symposium set a common platform for Consultants in ENT and ophthalmology to improve patient care services  -- To help clinicians enhance knowledge paving the way for better diagnosis, treatment...

Glenmark buoyed by speciality, generics businesses

Drug-maker Glenmark said that its specialty drugs and generics businesses performed well in the year ended March 2013.

“The US, India and Russia businesses continued to maintain its high growth trajectory,” said Glenn Saldanha, Chairman and Managing Director.

The company also made some progress on its research front with five new chemical entities and new biological entities getting into clinical trials, including Crofelemer which recently received approval from the US Food and Drug Administration for HIV associated diarrhoea, he added.

In the three months ended March 31, 2013, the company's revenues from the generics business was Rs 586 crore against Rs 468 crore in the corresponding period the previous year, a growth of 25 per cent. The specialty medicines business excluding out-licensing revenue was at Rs 741 crore against Rs 594 crore for the corresponding previous quarter, recording a growth of 24 per cent, the company said.